Psychedelics CEOs heartened by MDMA for PTSD study results as stocks maintain momentum

The success of a Phase 3 trial of MDMA for post-traumatic stress disorder (PTSD) which has put the therapy on track for U.S. Food and Drug Administration...

Related Keywords

Canada ,Toronto ,Ontario ,Canadian ,Payton Nyquvest ,Rick Doblin ,Filament Health Corp ,Life Sciences ,Small Pharma Inc ,Drug Administration ,Multidisciplinary Association For Psychedelic Studies ,Optimi Health Corp ,Public Benefit Corporation ,Cybin Inc ,Optimi Health ,Numinus Wellness Inc ,Mindset Pharma Inc ,Multidisciplinary Association ,Psychedelic Studies ,Benefit Corporation ,Psychedelic Spotlight ,Pharmala Biotech ,United States Listed ,